IDEXX Laboratories, Inc.
$562.97
$0.16(-0.03%)
IDEXX Laboratories, Inc.
IDXX
$562.97
$0.16(-0.03%)
IDEXX Laboratories, Inc.
IDXX
NASDAQ
$562.97
$0.16(-0.03%)
Chart
Upcoming Earnings
Next report date
Aug 3, 2026
Report period
Q3 2026
EPS Estimate
$3.94
Revenue Estimate
$1.20B
Key stats
52-Week Range$562.97
$465.00
$769.98
Market capitalization
$44.83BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
42.90Basic EPS (TTM)
$13.17Net income (TTM)
$1.06BRevenue (TTM)
$4.30BAvg. volume
527.01KBeta (1Y)
1.57Employees
11.00KMarket capitalization
$44.83BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
42.90Basic EPS (TTM)
$13.17Net income (TTM)
$1.06BRevenue (TTM)
$4.30BAvg. volume
527.01KBeta (1Y)
1.57Employees
11.00KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout IDEXX Laboratories, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky
Website
www.idexx.comHeadquarters
One IDEXX Drive, Westbrook, ME, 04092
IPO Date
1991-06-21
Identifiers
ISIN
US45168D1046Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary,...
Related Stocks
$305.90
1D:
0.7%
1Y:
4.8%
US03073E1055Healthcare
Mkt Cap
$59.51B
P/E Ratio TTM
36.3
Revenue TTM
$325.78B
Beta
0.72
Earnings TTM
$1.63B
Dividend Yield TTM
0.76%
$144.17
1D:
-1.5%
1Y:
39.7%
US0758871091Healthcare
Mkt Cap
$52.23B
P/E Ratio TTM
24.2
Revenue TTM
$21.92B
Beta
0.35
Earnings TTM
$1.76B
Dividend Yield TTM
2.50%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate